Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines

Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line

(2014) Radosław Januchowski et al.   BIOMEDICINE & PHARMACOTHERAPY

Drug Resistance in Cancer: An Overview

(2014) Genevieve Housman et al.   Cancers

Parallel Evolution under Chemotherapy Pressure in 29 Breast Cancer Cell Lines Results in Dissimilar Mechanisms of Resistance

(2012) Bálint Tegze et al.   PLoS One

MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines

(2012) Radosław Januchowski et al.   Biomed Research International

MDM2 antagonist nutlin-3a reverses mitoxantrone resistance by inhibiting breast cancer resistance protein mediated drug transport

(2011) Fan Zhang et al.   BIOCHEMICAL PHARMACOLOGY

The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines

(2011) Ana Podolski-Renić et al.   BIOMEDICINE & PHARMACOTHERAPY

Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development

(2011) K Moitra et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Expression of MRP1, BCRP, LRP, and ERCC1 in Advanced Non–Small-Cell Lung Cancer: Correlation With Response to Chemotherapy and Survival

(2009) Jian Li et al.   Clinical Lung Cancer

Ovarian cancer

(2009) Bryan T Hennessy et al.   LANCET

Nonplatinum Topotecan Combinations Versus Topotecan Alone for Recurrent Ovarian Cancer: Results of a Phase III Study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group

(2008) Jalid Sehouli et al.   JOURNAL OF CLINICAL ONCOLOGY